Edmonton, AB.
Montreal, QC.
J Obstet Gynaecol Can. 2023 Apr;45(4):273-282.e2. doi: 10.1016/j.jogc.2023.03.004.
To evaluate the benefits and risks of minimally invasive procedures in the management of patients with infertility and provide guidance to gynaecologists who manage common conditions in these patients.
Patients with infertility (inability to conceive after 12 months of unprotected intercourse) undergoing investigation and treatment.
BENEFITS, HARMS, AND COSTS: Minimally invasive reproductive surgery can be used to treat infertility, improve fertility treatment outcomes, or preserve fertility. All surgery has risks and associated complications. Reproductive surgery may not improve fertility outcomes and may, in some instances, damage ovarian reserve. All procedures have costs, which are borne either by the patient or their health insurance provider.
We searched English-language articles from January 2010 to May 2021 in PubMed/MEDLINE, Embase, Science Direct, Scopus, and Cochrane Library (see Appendix A for MeSH search terms).
The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix B (Tables B1 for definitions and B2 for interpretations of strong and conditional [weak] recommendations).
Gynaecologists who manage common conditions in patients with infertility.
RECOMMENDATIONS.
评估微创程序在不孕患者管理中的益处和风险,并为管理这些患者常见病症的妇科医生提供指导。
不孕(无保护性行为 12 个月后仍无法受孕)接受调查和治疗的患者。
益处、危害和成本:微创生殖手术可用于治疗不孕,改善生育治疗结果或保留生育能力。所有手术都有风险和相关并发症。生殖手术可能不会改善生育结果,在某些情况下,还可能损害卵巢储备。所有程序都有成本,要么由患者承担,要么由其健康保险提供者承担。
我们在 PubMed/MEDLINE、Embase、Science Direct、Scopus 和 Cochrane 图书馆中搜索了 2010 年 1 月至 2021 年 5 月的英文文章(请参见在线附录 B,表 B1 用于定义,表 B2 用于强推荐[弱]推荐的解释)。
作者使用推荐评估、制定和评估(GRADE)方法对证据质量和建议强度进行了评级。请参见在线附录 B(表 B1 用于定义,表 B2 用于强推荐[弱]推荐的解释)。
管理不孕患者常见病症的妇科医生。
建议。